Search

Your search keyword '"Grabe, Niels"' showing total 465 results

Search Constraints

Start Over You searched for: Author "Grabe, Niels" Remove constraint Author: "Grabe, Niels"
465 results on '"Grabe, Niels"'

Search Results

1. Interobserver reproducibility of cervical histology interpretation with and without p16 immunohistochemistry.

2. Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma

3. Common clonal origin of conventional T cells and induced regulatory T cells in breast cancer patients

4. Identification and regulation of the long non-coding RNA Heat2 in heart failure

5. Revisiting the Training of Logic Models of Protein Signaling Networks with a Formal Approach based on Answer Set Programming

6. HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice

7. CNN stability training improves robustness to scanner and IHC-based image variability for epithelium segmentation in cervical histology

8. Suppl. Figure 8 from Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma

9. Suppl. Figure 10 from Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma

10. Suppl. Figure 9 from Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma

11. Suppl. Table 2 from Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma

12. Supplementary Figure Legends from Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma

13. Supplementary Figure Legends from Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas

14. Supplementary Tables 1-2 from Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas

15. Suppl. Figure 2 from Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma

16. Supplementary Figures 1-5 from Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas

17. Figure S7 from Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival

18. Suppl. Figure 3 from Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma

19. Suppl. Figure 6 from Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma

20. Supplementary Data from Natural Killer Cells are Scarce in Colorectal Carcinoma Tissue Despite High Levels of Chemokines and Cytokines

21. Supplementary Tables from Surfactant Expression Defines an Inflamed Subtype of Lung Adenocarcinoma Brain Metastases that Correlates with Prolonged Survival

22. Suppl. Table 1, 3-8 from Identification of CRKII, CFL1, CNTN1, NME2, and TKT as Novel and Frequent T-Cell Targets in Human IDH-Mutant Glioma

23. Data from Cytotoxic T Cells and their Activation Status are Independent Prognostic Markers in Meningiomas

24. Data from Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy

25. Supplementary Figures 1-3, Table 1 from Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy

26. Segmentation of diagnostic tissue compartments on whole slide images with renal thrombotic microangiopathies (TMAs)

27. Spatio-temporal mathematical model describing the interplay between biomechanics and cell kinetics during fibrotic scar formation

28. Correlation between genomic index lesions and mpMRI and 68Ga-PSMA-PET/CT imaging features in primary prostate cancer

30. Identification of T cell target antigens in glioblastoma stem-like cells using an integrated proteomics-based approach in patient specimens

35. Molecular profiling of long-term survivors identifies a subgroup of glioblastoma characterized by chromosome 19/20 co-gain

36. Automated Evaluation of p16/Ki-67 Dual-Stain Cytology as a Biomarker for Detection of Anal Precancer in Men Who Have Sex With Men and Are Living With Human Immunodeficiency Virus

38. LOC283731 promoter hypermethylation prognosticates survival after radiochemotherapy in IDH1 wild-type glioblastoma patients

40. Therapeutic Effects of Inhibition of Sphingosine-1-Phosphate Signaling in HIF-2α Inhibitor-Resistant Clear Cell Renal Cell Carcinoma

45. HPV-related methylation signature predicts survival in oropharyngeal squamous cell carcinomas

48. Expression Analysis of Aldehyde Dehydrogenase 1A1 (ALDH1A1) in Colon and Rectal Cancer in Association with Prognosis and Response to Chemotherapy

49. Additional file 2 of Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma

50. Additional file 3 of Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma

Catalog

Books, media, physical & digital resources